Irish Life Investment Managers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Irish Life Investment Managers’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$85.4K	Buy	+2,760	New	+$73.4K	﹤0.01%	1020

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Irish Life Investment Managers's ALNY Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2013: 2,760 shares worth $85.4K. The stake represents ﹤0.01% of the portfolio and ranks #1020 among its holdings.

139 funds tracked by Wall St. Rank hold ALNY as of Q2 2013.

Irish Life Investment Managers held 2,760 shares of Alnylam Pharmaceuticals worth $85.4K as of Q2 2013.
Alnylam Pharmaceuticals was a new Irish Life Investment Managers position in Q2 2013.
Alnylam Pharmaceuticals made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1020 holding.
139 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.